Works matching IS 08853185 AND DT 2017 AND VI 32 AND IP 11
Results: 23
Glitazone use associated with reduced risk of Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Design optimization for clinical trials in early-stage manifest Huntington's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
It's not just the basal ganglia: Cerebellum as a target for dystonia therapeutics.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A PDE10A de novo mutation causes childhood-onset chorea with diurnal fluctuations.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dietary antioxidants and Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Falls in Parkinson's disease: A complex and evolving picture.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
What would James Parkinson think? A virtual dialogue on factors influencing the development of Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Low CSF 5-HIAA in Myoclonus Dystonia.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Issue Information - Table of Contents.
- Published in:
- Movement Disorders, 2017, v. 32, n. 11, p. n/a, doi. 10.1002/mds.26791
- Publication type:
- Article
Issue Information - Masthead.
- Published in:
- Movement Disorders, 2017, v. 32, n. 11, p. n/a, doi. 10.1002/mds.26792
- Publication type:
- Article
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Movement Disorders: Volume 32, Number 11, November 2017.
- Published in:
- Movement Disorders, 2017, v. 32, n. 11, p. n/a, doi. 10.1002/mds.27257
- Publication type:
- Article
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cognition and the course of prodromal Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article